Phendimetrazine Tartrate
NDC Package 12634-910-01
Package Information
Phendimetrazine Tartrate is phendimetrazine is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Marketed by Apotheca Inc., this product is identified by NDC 12634-910 and is authorized under FDA application NDA018074.
Identification & Billing
- RxCUI: 979543 - phendimetrazine tartrate 105 MG 24HR Extended Release Oral Capsule
- RxCUI: 979543 - 24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule
- RxCUI: 979543 - phendimetrazine 105 MG 24 HR Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 12634 - Apotheca Inc.
- 12634-910 - Phendimetrazine Tartrate
- 12634-910-01 - 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 12634-910 - Phendimetrazine Tartrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (12634-910). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 12634-910-01 identifies a specific commercial package of 100 capsule, extended release in 1 bottle of Phendimetrazine Tartrate, labeled by Apotheca Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apotheca Inc. on September 06, 1977. The current certification is valid through December 31, 2019.
What are the primary indications for this medication?
Phendimetrazine is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. It is not known how this medication helps people to lose weight. It may work by decreasing your appetite, increasing the amount of energy used by your body, or by affecting certain parts of the brain. This medication is an appetite suppressant and belongs to a class of drugs called sympathomimetic amines.
How is this Apotheca Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 12634091001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
